Publication Radar · Source metadata
StochIKM: Automated High-Fidelity Reconstruction of Individual Patient Data from Published Kaplan-Meier Curves
Publication record
Bibliographic evidence describes where and when a record appeared. It does not validate scientific claims.
First public release: 2026-10-21 · Indexed by Pub-AI: 2026-10-25 UTC
StochIKM: Automated High-Fidelity Reconstruction of Individual Patient Data from Published Kaplan-Meier Curves
Preprint posted: 2026-10-21 · Original record ↗
- arxiv
- 2610.29122
Explicit source versions (1)
- v2 · 2026-10-22
- Preprint available
Source date: 2026-10-21 · First detected: 2026-10-25 UTC · Historical baseline
Source evidence (2)
- Official evidence ↗ · OAI arXiv created; not header datestamp (official metadata)
- Official evidence ↗ · atom:published (official metadata)
- Explicit source version detected · v2
Source date: 2026-10-22 · First detected: 2026-10-25 UTC · Historical baseline
Source evidence (1)
- Official evidence ↗ · atom:id explicit version (official metadata)
Abstract · arxiv
Individual patient data are the gold standard for secondary analysis of time-to-event evidence, but they are rarely released, and reconstruction from a published Kaplan-Meier figure could help. Existing methods all claim high fidelity, each judged by whichever agreements it happens to achieve, and each returns a single dataset although the map from figure to data is not bijective. We define fidelity explicitly: a dataset is admissible when it reproduces the risk table exactly, follows the digitized curve to within the image resolution, and respects the printed median, interval and event count. We propose StochIKM, a stochastic algorithm that digitizes the figure with a vision-capable language model and uses the high-fidelity definition as constraints, returning an admissible set of individual patient datasets. A solution is guaranteed to exist whenever the figure has been read correctly, so a failure indicts either the published figure or its digitization. In simulation and in 79 arms from published oncology trials, StochIKM reproduces the published risk tables and medians more closely than LLM-improved IPDfromKM, a high-impact alternative.